Clinical Study | Office of Clinical Research

Phase III Trial Of Radiotherapy Plus Cetuximab Versus Chemoradiotherapy In Hpv-Associated Oropharynx Cancer

Posted Date: May 15, 2019

Investigator: Jordan Kharofa
Type of Study: Drug

This study is to compare the good and bad effects of two standard treatments for head and neck cancer: radiation therapy and Cisplatin or radiation therapy and cetuximab. This study is being done in patients whose head and neck cancer was caused by HPV. Treatment will last approximately 6-8 weeks wi

Criteria:

Eligible Patients Must Have Cancer Of The Head And Neck

Keywords:

Head And Neck Cancer, Hpv, Mouth Cancer, Oropharynx Cancer, R1016

For More Information:

Uc Cancer Center
513-584-7698
kastla@ucmail.uc.edu

Name*
First Last
Gender*
- Male
- Female
Age*
Phone*
Email*
How did you hear about us?*
Future Communication*
- By submitting this form, I am agreeing to receive future communication about participating in an upcoming research study.
CAPTCHA
This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.
List